These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16544907)

  • 1. Powder and other divided solids mixing. Scale-up and parametric study of a ribbon blender used in pharmaceutical powders mixing.
    Côté P; Abatzoglou N
    Pharm Dev Technol; 2006 Feb; 11(1):29-45. PubMed ID: 16544907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-line quantification of drug and excipients in cohesive powder blends by near infrared spectroscopy.
    Liew CV; Karande AD; Heng PW
    Int J Pharm; 2010 Feb; 386(1-2):138-48. PubMed ID: 19922776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of operational parameters and feed preparation in a convective batch ribbon powder mixer.
    Yeow ST; Shahar A; Abdul Aziz N; Anuar MS; Yusof YA; Taip FS
    Drug Des Devel Ther; 2011; 5():465-9. PubMed ID: 22162640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer.
    Kornchankul W; Hamed E; Parikh NH; Sakr A
    Pharmazie; 2002 Jan; 57(1):49-53. PubMed ID: 11836931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring blending of pharmaceutical powders with multipoint NIR spectroscopy.
    Scheibelhofer O; Balak N; Wahl PR; Koller DM; Glasser BJ; Khinast JG
    AAPS PharmSciTech; 2013 Mar; 14(1):234-44. PubMed ID: 23263752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic energy density and agglomerate abrasion rate during blending of agglomerates into powders.
    Willemsz TA; Hooijmaijers R; Rubingh CM; Tran TN; Frijlink HW; Vromans H; van der Voort Maarschalk K
    Eur J Pharm Sci; 2012 Jan; 45(1-2):211-5. PubMed ID: 22127372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the mixing effectiveness of a new powder mixer.
    Palmieri GF; Lovato D; Marchitto L; Zanchetta A; Martelli S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):81-8. PubMed ID: 15605601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of powder blending using on-line near-infrared measurements.
    Ufret C; Morris K
    Drug Dev Ind Pharm; 2001 Aug; 27(7):719-29. PubMed ID: 11694020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Microcrystalline Cellulose for Improving Drug Content Uniformity in Tablet Manufacturing Using Direct Powder Compression.
    Nakamura S; Tanaka C; Yuasa H; Sakamoto T
    AAPS PharmSciTech; 2019 Mar; 20(4):151. PubMed ID: 30903317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roller compaction of moist pharmaceutical powders.
    Wu CY; Hung WL; Miguélez-Morán AM; Gururajan B; Seville JP
    Int J Pharm; 2010 May; 391(1-2):90-7. PubMed ID: 20176096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of particle size and blender size on blending performance of bi-component granular mixing: A DEM and experimental study.
    Tanabe S; Gopireddy SR; Minami H; Ando S; Urbanetz NA; Scherließ R
    Eur J Pharm Sci; 2019 Jun; 134():205-218. PubMed ID: 31034985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixing of cohesive pharmaceutical formulations in tote (bin) blenders.
    Sudah OS; Arratia PE; Coffin-Beach D; Muzzio FJ
    Drug Dev Ind Pharm; 2002 Sep; 28(8):905-18. PubMed ID: 12378960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of a pharmaceutical powder mixing process in a tote blender via DEM simulations.
    Benque B; Orefice L; Forgber T; Habeler M; Schmid B; Remmelgas J; Khinast J
    Int J Pharm; 2024 Jun; 658():124224. PubMed ID: 38740105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Process characterization of powder blending by near-infrared spectroscopy: blend end-points and beyond.
    Shi Z; Cogdill RP; Short SM; Anderson CA
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):738-45. PubMed ID: 18486399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of eliminating premixing for the production of pellets in a rotary processor.
    Gu L; Liew CV; Soh JL; Heng PW
    Pharm Dev Technol; 2006; 11(2):159-65. PubMed ID: 16749526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microspectroscopic FT-IR mapping system as a tool to assess blend homogeneity of drug-excipient mixtures.
    Lee TH; Lin SY
    Eur J Pharm Sci; 2004 Oct; 23(2):117-22. PubMed ID: 15450999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of tablet weight variability by optimizing paddle speed in the forced feeder of a high-speed rotary tablet press.
    Peeters E; De Beer T; Vervaet C; Remon JP
    Drug Dev Ind Pharm; 2015 Apr; 41(4):530-9. PubMed ID: 24502268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Powder die filling under gravity and suction fill mechanisms.
    Baserinia R; Sinka IC
    Int J Pharm; 2019 May; 563():135-155. PubMed ID: 30742983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicomponent granular mixing in a Bohle bin Blender-Experiments and simulation.
    Sen K; Velez N; Anderson C; Drennen Iii JK; Zidan AS; Chaudhuri B
    Int J Pharm; 2020 Mar; 578():119131. PubMed ID: 32057888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.